MedPath

The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.

Not Applicable
Completed
Conditions
Cerebral Metabolism and Perfusion
Interventions
Other: mild hypo- and hyperventilation
Registration Number
NCT00766103
Lead Sponsor
Tampere University Hospital
Brief Summary

Incidence of hypo- and hypercarbia during induced hypothermia after cardiac arrest is high. The original report from HACA-group reported that hypothermia treated patients had improved survival and neurological outcome. Suprisingly, in that trial normocarbia was not achieved even though the aim was set for ventilatory support as normoventilation. This study aims to investigate the effects of mild hypo- and hypercarbia on cerebral perfusion (blood flow, intracranial pressure) and metabolism (microdialysate metabolites). We hypothesize that uncontrolled ventilatory suppport may render the patients in risk of exacerbation of neuronal damage, conversely, further improvement in outcome may be achieved with succesfull ventilatory management. We intend to enroll 10 out-of-hospital cardiac arrest patients succesfully resuscitated and subsequently treated with controlled hypothermia for 24 hours. The patients in need of anticoagulation are excluded. We plan to induce mild hypocarbia and hypercarbia during and after induced hypothermia. Metabolic and perfusion data are collected with clinically used methods such as transcranial doppler, intracranial pressure measurement, near infrared spectroscopy, jugular bulb, intracerebral microdialysis).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
8
Inclusion Criteria

succesfull resuscitation of out of hospital cardiac arrest, primary rhytm shockable

Exclusion Criteria
  • known coagulopathy, need of anticoagulation therapy, need of interventional cardiological procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
crossover: hypo- and hypercarbiamild hypo- and hyperventilation-
Primary Outcome Measures
NameTimeMethod
surrogate physiological endpoints60minutes
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Critical Care Medicine Research Group/ department of intensive care

🇫🇮

Tampere, Pirkanmaa, Finland

© Copyright 2025. All Rights Reserved by MedPath